Results 281 to 290 of about 1,050,029 (354)
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
Large language models and global health equity: a roadmap for equitable adoption in LMICs. [PDF]
Chen H +15 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Breaking down the Dyslipidemia-Stroke Relationship in Southeast Asian American Subgroups: Advancing Toward Cardiovascular Health Equity. [PDF]
Vo J, Roman YM.
europepmc +1 more source
Intersectoral Collaboration to Develop Health Equity Indicators in Iran
Mohammadreza Zakeri +7 more
openalex +1 more source
Pharmacokinetic profiles of sertraline in pregnancy as a predictor of postpartum depressive symptoms
Aim To characterize pharmacokinetic changes of sertraline and its metabolite during pregnancy and postpartum, and their relationship to maternal postpartum depressive symptoms. Methods This was a prospective observational, longitudinal study of pregnant women with a major depressive disorder treated with sertraline (N = 185 women, 205 pregnancies ...
Sílvia M. Illamola +8 more
wiley +1 more source

